Skip to Main Content
Everyone (Public)

Yale Neuropsychology Conference 2024

CME Credits: a maximum of 7.0 hours AMA PRA Category 1 Credits

We are thrilled to welcome you to the Yale Neuropsychology Conference 2024!

In this full day conference, we will explore cutting-edge research and advancements in understanding, diagnosing, and treating cognitive disorders. Our conference will feature five engaging sessions led by esteemed panels in their respective fields including featured renowned experts, Drs. Hal Blumenfeld, Franchesca Arias, Christopher van Dyck.

Session I will focus on cognitive behavioral therapy for headache management. Session II will provide insights into the latest research on atypical presentations of Alzheimer's disease and an update on pharmacological treatments. In Session III we will delve into the intricate workings of neuroanatomy, consciousness, and coping with the stigma surrounding epilepsy. Session IV will explore how the built environment affects cognitive aging and learn about innovative approaches to improve cognitive health. In Session V we will learn about sleep issues and hearing loss as risk factors for cognitive problems; and about an evidence-based self-management program to help adults with seizure disorders manage and cope with memory challenges.

Register today and join our multidisciplinary panel of experts as we explore the latest advancements in cognitive health!

Learning Objectives

Upon completion of this program, participants should be able to:

  • understand the prevalence of headache disorders in the VA population.
  • describe the importance of biopsychosocial perspective of behavioral interventions for headache.
  • explain the key components of cognitive behavioral therapy for headache.
  • recognize and assess non-amnestic Alzheimer’s variants including posterior cortical atrophy, logopenic aphasia, and frontal and motor variants.
  • evaluate the clinical and biomarker evidence for lecanemab as a potential disease-modifying therapy for Alzheimer’s disease.
  • identify subcortical arousal areas contributing to normal conscious awareness.
  • use knowledge of arousal networks to explain mechanism of impaired consciousness in temporal lobe seizures and apply principles of neurostimulation to develop a novel approach for restoring consciousness in temporal lobe seizures
  • articulate various barriers to functional and social independence in patients with seizures.
  • identify examples of internalized and enacted stigma (i.e., discrimination) faced by people with epilepsy.
  • discuss a novel approach to applying cognitive-behavioral treatment concepts to reduce internalized epilepsy stigma.
  • describe the methodologies used to characterize neighborhood disadvantage in the Yale ADRC in Connecticut, and local neighborhood characteristics relevant to the interpretation of these findings.
  • discuss some of the challenges encountered in the process of characterizing neighborhood disadvantage, such as data limitations and spatial heterogeneity, while also discussing potential alternatives to support this effort.
  • list two dimensions of the “built environment” domain that extend beyond infrastructure.
  • understand how different dimensions of built environment work independently and synergistically to affect psychological and cognitive health.
  • describe the nature of the built environment domain within a social, economic, and historical context to appreciate its complexity and its significance in shaping community health outcomes.
  • critically examine empirical evidence on built environment and explore opportunities for enhancing healthcare delivery, developing preventive interventions, and addressing health inequities.
  • discuss the development and core components of the evidence-based epilepsy self-management program HOBSCOTCH (HOme Based Self-management and COgnitive Training CHanges Lives).
  • summarize a basic understanding of the relationship between sleep and cognition in older adults.
  • identify sleep patterns that indicate elevated risk for cognitive decline and/or dementia
  • describe the evidence base for patient benefit resulting from participation in the HOBSCOTCH program.
  • describe existing and potential mechanisms for integrating HOBSCOTCH into neuropsychology clinical care streams.
  • describe how hearing loss is an important treatable risk factor for cognitive decline and dementia.

Accreditation Statement

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement The Yale School of Medicine designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this directly provided live course activity.

Disclosure Policy It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement

Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Pre-Conference Afternoon Activity !

Thursday May 02, 2024 at 04:00 PM ET

Guided tour of The Cushing Center at Yale’s Harvey Cushing / John Hay Whitney Medical Library

About the Cushing Center | Harvey Cushing/John Hay Whitney Medical Library (

The Cushing-Eisenhardt Collaboration: Founding of the Brain Tumor Registry and Neuropathology Collection < Neuropathology (

If you are attending the conference in person and are interested in joining a group tour of The Cushing Center, please email your name to us in advance at:

Event Schedule





Conferences and Symposia


Breakfast, Lunch, and Snacks